Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3407629rdf:typepubmed:Citationlld:pubmed
pubmed-article:3407629lifeskim:mentionsumls-concept:C0376358lld:lifeskim
pubmed-article:3407629lifeskim:mentionsumls-concept:C0796396lld:lifeskim
pubmed-article:3407629pubmed:issue4lld:pubmed
pubmed-article:3407629pubmed:dateCreated1988-9-14lld:pubmed
pubmed-article:3407629pubmed:abstractTextWe present the improved implant technique, intraoperative and postoperative complications, local control, and survival of 67 patients with cancer of the prostate treated by means of percutaneous transperineal template permanent 125iodine interstitial endocurietherapy (ECT). This ECT technique is a simple, easily learned, accurate and rapid procedure that can be performed without subjecting the patient to celiotomy. The use of vicryl carriers for permanent 125iodine implantation of the prostate with the percutaneous transperineal template technique prevents seed loss and permits implantation of patients after transurethral resection of the prostate (TURP).lld:pubmed
pubmed-article:3407629pubmed:languageenglld:pubmed
pubmed-article:3407629pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3407629pubmed:citationSubsetIMlld:pubmed
pubmed-article:3407629pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3407629pubmed:statusMEDLINElld:pubmed
pubmed-article:3407629pubmed:monthAuglld:pubmed
pubmed-article:3407629pubmed:issn0277-3732lld:pubmed
pubmed-article:3407629pubmed:authorpubmed-author:LynchGGlld:pubmed
pubmed-article:3407629pubmed:authorpubmed-author:KumarP PPPlld:pubmed
pubmed-article:3407629pubmed:authorpubmed-author:JonesE OEOlld:pubmed
pubmed-article:3407629pubmed:authorpubmed-author:BartoneF FFFlld:pubmed
pubmed-article:3407629pubmed:authorpubmed-author:GoodR RRRlld:pubmed
pubmed-article:3407629pubmed:issnTypePrintlld:pubmed
pubmed-article:3407629pubmed:volume11lld:pubmed
pubmed-article:3407629pubmed:ownerNLMlld:pubmed
pubmed-article:3407629pubmed:authorsCompleteYlld:pubmed
pubmed-article:3407629pubmed:pagination479-89lld:pubmed
pubmed-article:3407629pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:3407629pubmed:meshHeadingpubmed-meshheading:3407629-...lld:pubmed
pubmed-article:3407629pubmed:meshHeadingpubmed-meshheading:3407629-...lld:pubmed
pubmed-article:3407629pubmed:meshHeadingpubmed-meshheading:3407629-...lld:pubmed
pubmed-article:3407629pubmed:meshHeadingpubmed-meshheading:3407629-...lld:pubmed
pubmed-article:3407629pubmed:meshHeadingpubmed-meshheading:3407629-...lld:pubmed
pubmed-article:3407629pubmed:meshHeadingpubmed-meshheading:3407629-...lld:pubmed
pubmed-article:3407629pubmed:meshHeadingpubmed-meshheading:3407629-...lld:pubmed
pubmed-article:3407629pubmed:meshHeadingpubmed-meshheading:3407629-...lld:pubmed
pubmed-article:3407629pubmed:meshHeadingpubmed-meshheading:3407629-...lld:pubmed
pubmed-article:3407629pubmed:meshHeadingpubmed-meshheading:3407629-...lld:pubmed
pubmed-article:3407629pubmed:meshHeadingpubmed-meshheading:3407629-...lld:pubmed
pubmed-article:3407629pubmed:year1988lld:pubmed
pubmed-article:3407629pubmed:articleTitleTransperineal 125iodine endocurietherapy of prostate cancer.lld:pubmed
pubmed-article:3407629pubmed:affiliationDivision of Radiation Oncology, University of Nebraska Medical Center, Omaha 68150.lld:pubmed
pubmed-article:3407629pubmed:publicationTypeJournal Articlelld:pubmed